Final outcome of IBS' rights issue


Final outcome of IBS' rights issue 

IBS' new share issue with preferential rights for the Company's existing
shareholders has been completed. Deccan Value Advisors, having issued a
subscription guarantee, subscribed for its pro rata share of the rights issue
and an additional 75,000 class A shares and an additional 11,087,943 class B
shares. Accordingly, the rights issue was subscribed for in its entirety.

According to a July 4 Deccan Value Advisors press release, Deccan Value Advisors
owns 20.0 percent of the shares and 38.7 percent of the votes in IBS.
As a consequence of the rights issue, the number of shares in IBS increases by
1,575,000 class A shares and 40,229,015 class B shares. 

Following the issue, 4,725,000 class A shares and 120,687,045 class B shares
will be outstanding.
Trading in the new class B shares on OMX Nordic Exchange Stockholm is scheduled
to commence on July 17, 2008.
The rights issue will provide the company with approximately SEK 397 million
before transaction costs.

Additional class B shares will be issued shortly as consideration for Deccan
Value Advisors subscription guarantee. The exact number of shares issued will be
stated in a separate press release as soon as the formal resolution to issue the
shares has been adopted.

IBS AB

Board of Directors

For further information, please contact:

Investor Relations Director
Oskar Ahlberg
Tel: +46 (0)70 244 24 75, 
oskar.ahlberg@ibs.net

IBS in brief
With over 30 years of supply chain expertise, IBS is a leading provider of
complete ERP solutions. IBS focuses on mid-sized and large distribution
companies, as well as sales and manufacturing subsidiaries of international
groups, mainly within industries such as automotive, electrical, food,
industrial supplies, paper, pharmaceutical, publishing and wholesale
distribution. More than 5,000 customers across some 40 countries use IBS
software to gain fast and measurable returns on IT investments.

IBS B share is listed on OMX Nordic Exchange Stockholm. For more information,
please visit www.ibs.net

Attachments

07102118.pdf